,

Yinglian Li1, Yuan Fang1, DongLi Li2

  • 1Department of Oncology, Kaiyuan Langdong Hospital of Guangxi Medical University, Nanning, China.

Frontiers in medicine
|July 26, 2024
PubMed
概括

这项研究开发了一个新的预后模型,使用六个与炎症相关的基因来预测肝细胞癌 (HCC) 患者的生存率. 风险评分作为HCC预后的独立预测指标.